CL:0002032

Name:	hematopoietic oligopotent progenitor cell
Namespace:	FANTOM
Definition:	"A hematopoietic oligopotent progenitor cell that has the ability to differentiate into limited cell types but lacks lineage cell markers and self renewal capabilities. Cell lacks hematopoeitic lineage markers." [GOC:tfm, PMID:19022770]
Created by:	tmeehan
Creation date:	2010-01-06T03:43:27Z

Ontology association <br>Each term has an is_a parent in the Cell ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to Cell ontologies.<br><br>link to ontology dataset<br>data

---

Parents

is_a:	CL:0008001(hematopoietic precursor cell)
develops_from:	CL:0000837(hematopoietic multipotent progenitor cell)

Children

is a:	CL:0000049 (common myeloid progenitor),CL:0000050 (megakaryocyte-erythroid progenitor cell),CL:0000051 (common lymphoid progenitor),CL:0001060 (hematopoietic oligopotent progenitor cell, lineage-negative),CL:0002009 (macrophage dendritic cell progenitor)
disjoint from:	CL:0000837 (hematopoietic multipotent progenitor cell),CL:0002031 (hematopoietic lineage restricted progenitor cell)
develops from:	CL:0002031 (hematopoietic lineage restricted progenitor cell)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples<br>It includes FANTOM5 samples that overlay the Cell ontology.

---

Human (Homo sapiens)

• 12122-128C7 (common myeloid progenitor CMP, biol_rep1)
• 12123-128C8 (granulocyte macrophage progenitor GMP, biol_rep1)
• 12125-128D1 (common myeloid progenitor CMP, biol_rep2)
• 12126-128D2 (granulocyte macrophage progenitor GMP, biol_rep2)
• 12128-128D4 (common myeloid progenitor CMP, biol_rep3)
• 12129-128D5 (granulocyte macrophage progenitor GMP, biol_rep3)
• 12130-128D6 (common myeloid progenitor CMP, donor1)
• 12131-128D7 (granulocyte macrophage progenitor, donor1)
• 12134-128E1 (common myeloid progenitor CMP, donor2)
• 12135-128E2 (granulocyte macrophage progenitor, donor2)

... further results Mouse (Mus musculus)

• 12122-128C7 (common myeloid progenitor CMP, biol_rep1)
• 12123-128C8 (granulocyte macrophage progenitor GMP, biol_rep1)
• 12125-128D1 (common myeloid progenitor CMP, biol_rep2)
• 12126-128D2 (granulocyte macrophage progenitor GMP, biol_rep2)
• 12128-128D4 (common myeloid progenitor CMP, biol_rep3)
• 12129-128D5 (granulocyte macrophage progenitor GMP, biol_rep3)
• 12130-128D6 (common myeloid progenitor CMP, donor1)
• 12131-128D7 (granulocyte macrophage progenitor, donor1)
• 12134-128E1 (common myeloid progenitor CMP, donor2)
• 12135-128E2 (granulocyte macrophage progenitor, donor2)

... further results

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with CL:0002032 (hematopoietic oligopotent progenitor cell), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

---

Copy Excel CSV PDF

Search:

P-value	FFCP	Short description

P-value	FFCP	Short description
4.27e-116	FFCP PHASE2:Hg19::chr2:68592394..68592405,+	p2@PLEK
4.27e-116	FFCP PHASE1:Hg19::chr2:68592394..68592405,+	p2@PLEK
1.75e-114	FFCP PHASE1:Hg19::chr1:206730535..206730549,+	p4@RASSF5
1.75e-114	FFCP PHASE2:Hg19::chr1:206730535..206730549,+	p4@RASSF5
2.07e-105	FFCP PHASE2:Hg19::chr5:169724839..169724855,-	p3@LCP2
2.07e-105	FFCP PHASE1:Hg19::chr5:169724839..169724855,-	p3@LCP2
2.11e-105	FFCP PHASE1:Hg19::chr7:50344251..50344288,+	p3@IKZF1
2.11e-105	FFCP PHASE2:Hg19::chr7:50344251..50344288,+	p3@IKZF1
7.74e-104	FFCP PHASE1:Hg19::chr2:143886909..143886922,+	p2@ARHGAP15
7.74e-104	FFCP PHASE2:Hg19::chr2:143886909..143886922,+	p2@ARHGAP15
1.17e-102	FFCP PHASE1:Hg19::chr2:143886890..143886904,+	p4@ARHGAP15
1.17e-102	FFCP PHASE2:Hg19::chr2:143886890..143886904,+	p4@ARHGAP15
1.97e-102	FFCP PHASE2:Hg19::chr2:143886927..143886938,+	p3@ARHGAP15
1.97e-102	FFCP PHASE1:Hg19::chr2:143886927..143886938,+	p3@ARHGAP15
9.02e-102	FFCP PHASE1:Hg19::chr1:206730484..206730499,+	p2@RASSF5
9.02e-102	FFCP PHASE2:Hg19::chr1:206730484..206730499,+	p2@RASSF5
4.83e-101	FFCP PHASE2:Hg19::chr2:144021511..144021516,+	p@chr2:144021511..144021516, +
4.83e-101	FFCP PHASE1:Hg19::chr2:144021511..144021516,+	p@chr2:144021511..144021516, +
9.7e-101	FFCP PHASE1:Hg19::chr1:202129704..202129762,-	p1@PTPN7
9.7e-101	FFCP PHASE2:Hg19::chr1:202129704..202129762,-	p1@PTPN7
1.17e-100	FFCP PHASE2:Hg19::chr1:151129103..151129130,+	p2@TNFAIP8L2
1.17e-100	FFCP PHASE1:Hg19::chr1:151129103..151129130,+	p2@TNFAIP8L2
1.38e-100	FFCP PHASE1:Hg19::chr10:11207485..11207496,+	p9@CELF2
1.38e-100	FFCP PHASE2:Hg19::chr10:11207485..11207496,+	p9@CELF2
1.99e-100	FFCP PHASE1:Hg19::chr7:45018571..45018589,-	p3@MYO1G
1.99e-100	FFCP PHASE2:Hg19::chr7:45018571..45018589,-	p3@MYO1G
3.18e-100	FFCP PHASE1:Hg19::chr21:15918672..15918683,-	p2@SAMSN1
3.18e-100	FFCP PHASE2:Hg19::chr21:15918672..15918683,-	p2@SAMSN1
9.87e-100	FFCP PHASE1:Hg19::chr19:2085323..2085357,-	p2@MOB3A
9.87e-100	FFCP PHASE2:Hg19::chr19:2085323..2085357,-	p2@MOB3A
1.55e-99	FFCP PHASE2:Hg19::chr11:73694239..73694253,-	p2@UCP2
1.55e-99	FFCP PHASE1:Hg19::chr11:73694239..73694253,-	p2@UCP2
2.66e-99	FFCP PHASE1:Hg19::chr12:54891496..54891526,+	p2@NCKAP1L
2.66e-99	FFCP PHASE2:Hg19::chr12:54891496..54891526,+	p2@NCKAP1L
4.81e-98	FFCP PHASE2:Hg19::chr1:26872324..26872362,+	p1@RPS6KA1
4.81e-98	FFCP PHASE1:Hg19::chr1:26872324..26872362,+	p1@RPS6KA1
1.92e-97	FFCP PHASE1:Hg19::chr3:151962118..151962192,+	p@chr3:151962118..151962192, +
1.92e-97	FFCP PHASE2:Hg19::chr3:151962118..151962192,+	p@chr3:151962118..151962192, +
6.74e-97	FFCP PHASE1:Hg19::chr9:273038..273076,+	p2@DOCK8
6.74e-97	FFCP PHASE2:Hg19::chr9:273038..273076,+	p2@DOCK8
1.01e-96	FFCP PHASE1:Hg19::chr22:18260077..18260127,+	p1@LINC00528
1.01e-96	FFCP PHASE2:Hg19::chr22:18260077..18260127,+	p1@LINC00528
1.44e-96	FFCP PHASE1:Hg19::chr7:45018686..45018710,-	p2@MYO1G
1.44e-96	FFCP PHASE2:Hg19::chr7:45018686..45018710,-	p2@MYO1G
1.49e-96	FFCP PHASE2:Hg19::chr17:56415424..56415454,-	p@chr17:56415424..56415454, -
1.49e-96	FFCP PHASE1:Hg19::chr17:56415424..56415454,-	p@chr17:56415424..56415454, -
1.74e-96	FFCP PHASE2:Hg19::chr19:2085302..2085320,-	p3@MOB3A
1.74e-96	FFCP PHASE1:Hg19::chr19:2085302..2085320,-	p3@MOB3A
2.28e-96	FFCP PHASE1:Hg19::chr19:1067256..1067270,+	p4@HMHA1
2.28e-96	FFCP PHASE2:Hg19::chr19:1067256..1067270,+	p4@HMHA1
2.72e-96	FFCP PHASE2:Hg19::chr1:206730595..206730630,+	p3@RASSF5
2.72e-96	FFCP PHASE1:Hg19::chr1:206730595..206730630,+	p3@RASSF5
6.74e-96	FFCP PHASE1:Hg19::chr2:24149046..24149063,+	p@chr2:24149046..24149063, +
6.74e-96	FFCP PHASE2:Hg19::chr2:24149046..24149063,+	p@chr2:24149046..24149063, +
7.4e-96	FFCP PHASE2:Hg19::chr16:50715172..50715194,-	p2@SNX20
7.4e-96	FFCP PHASE1:Hg19::chr16:50715172..50715194,-	p2@SNX20
1.4e-95	FFCP PHASE2:Hg19::chr1:161039647..161039744,-	p1@ARHGAP30
1.4e-95	FFCP PHASE1:Hg19::chr1:161039647..161039744,-	p1@ARHGAP30
1.59e-95	FFCP PHASE2:Hg19::chr19:17862274..17862335,+	p2@FCHO1
1.59e-95	FFCP PHASE1:Hg19::chr19:17862274..17862335,+	p2@FCHO1
1.6e-95	FFCP PHASE2:Hg19::chr7:45018602..45018625,-	p1@MYO1G
1.6e-95	FFCP PHASE1:Hg19::chr7:45018602..45018625,-	p1@MYO1G
1.69e-95	FFCP PHASE1:Hg19::chr1:39680895..39680915,+	p7@MACF1
1.69e-95	FFCP PHASE2:Hg19::chr1:39680895..39680915,+	p7@MACF1
1.81e-95	FFCP PHASE1:Hg19::chr16:50715196..50715235,-	p1@SNX20
1.81e-95	FFCP PHASE2:Hg19::chr16:50715196..50715235,-	p1@SNX20
2.17e-95	FFCP PHASE2:Hg19::chr19:49842010..49842054,+	p@chr19:49842010..49842054, +
2.17e-95	FFCP PHASE1:Hg19::chr19:49842010..49842054,+	p@chr19:49842010..49842054, +
3.63e-95	FFCP PHASE2:Hg19::chr19:36393354..36393363,+	p4@HCST
3.63e-95	FFCP PHASE1:Hg19::chr19:36393354..36393363,+	p4@HCST
8.4e-95	FFCP PHASE1:Hg19::chr11:64107705..64107718,+	p2@CCDC88B
8.4e-95	FFCP PHASE2:Hg19::chr11:64107705..64107718,+	p2@CCDC88B
9.04e-95	FFCP PHASE2:Hg19::chr12:57871853..57871879,-	p6@ARHGAP9
9.04e-95	FFCP PHASE1:Hg19::chr12:57871853..57871879,-	p6@ARHGAP9
9.66e-95	FFCP PHASE1:Hg19::chr5:176936817..176936841,-	p2@DOK3
9.66e-95	FFCP PHASE2:Hg19::chr5:176936817..176936841,-	p2@DOK3
1.13e-94	FFCP PHASE2:Hg19::chr7:50344289..50344323,+	p1@IKZF1
1.13e-94	FFCP PHASE1:Hg19::chr7:50344289..50344323,+	p1@IKZF1
1.89e-94	FFCP PHASE2:Hg19::chr1:111415786..111415804,+	p2@CD53
1.89e-94	FFCP PHASE1:Hg19::chr1:111415786..111415804,+	p2@CD53
2.1e-94	FFCP PHASE2:Hg19::chr5:169064317..169064332,+	p2@DOCK2
2.1e-94	FFCP PHASE1:Hg19::chr5:169064317..169064332,+	p2@DOCK2
2.54e-94	FFCP PHASE1:Hg19::chrX:128913876..128913904,+	p2@SASH3
2.54e-94	FFCP PHASE2:Hg19::chrX:128913876..128913904,+	p2@SASH3
3.11e-94	FFCP PHASE1:Hg19::chr7:50343634..50343717,+	p2@IKZF1
3.11e-94	FFCP PHASE2:Hg19::chr7:50343634..50343717,+	p2@IKZF1
3.55e-94	FFCP PHASE2:Hg19::chrX:48547205..48547222,+	p2@WAS
3.55e-94	FFCP PHASE1:Hg19::chrX:48547205..48547222,+	p2@WAS
3.94e-94	FFCP PHASE2:Hg19::chr20:34078776..34078819,-	p1@ENST00000453914
3.94e-94	FFCP PHASE1:Hg19::chr20:34078776..34078819,-	p1@ENST00000453914
4.27e-94	FFCP PHASE1:Hg19::chr1:31206575..31206590,-	p@chr1:31206575..31206590, -
4.27e-94	FFCP PHASE2:Hg19::chr1:31206575..31206590,-	p@chr1:31206575..31206590, -
8.14e-94	FFCP PHASE2:Hg19::chr4:80994619..80994633,-	p6@ANTXR2
8.14e-94	FFCP PHASE1:Hg19::chr4:80994619..80994633,-	p6@ANTXR2
1.02e-93	FFCP PHASE1:Hg19::chr1:31230687..31230701,-	p3@LAPTM5
1.02e-93	FFCP PHASE2:Hg19::chr1:31230687..31230701,-	p3@LAPTM5
1.2e-93	FFCP PHASE2:Hg19::chrX:30595907..30595941,-	p2@CXorf21
1.2e-93	FFCP PHASE1:Hg19::chrX:30595907..30595941,-	p2@CXorf21
1.83e-93	FFCP PHASE1:Hg19::chr1:31206388..31206521,-	p@chr1:31206388..31206521, -
1.83e-93	FFCP PHASE2:Hg19::chr1:31206388..31206521,-	p@chr1:31206388..31206521, -

Showing 1 to 100 of 100 entries